15442-64-5
基本信息
原卟啉锌
三水合原卟啉锌
原卟啉锌(II)
三水合原卟啉锌,96%
锌原卟啉(ZNPPIX)
原卟啉 IX 锌(II) 络合物
3,3'-(3,8,13,17-四甲基-7,12-二乙烯基卟啉-2,18-二基)二丙酸锌
PROTOPORPHYRINATO ZINC
Zinc protoporphyrin trihydrate
Zinc protoporphyrin trihydrate, 95+%
PROTOPORPHYRINATO ZINC ISO 9001:2015 REACH
Zinc Protoporphyrin IX DISCONTINUED, offer Z439970
Zinc (II) Protoporphyrin IX - CAS 15442-64-5 - Calbiochem
Zinc(II) 3,3'-(3,8,13,17-tetramethyl-7,12-divinylporphyrin-2,18-diyl)dipropionate
dihydrogen [3,8,13,17-tetramethyl-7,12-divinyl-21H,23H-porphine-2,18-dipropionato(4-)-N21,N22,N23,N24]zincate(4-)
物理化学性质
| RTECS号 | ZG9210300 |
| 储存条件 | Store at RT |
| 溶解度 | DMSO : 50 mg/mL (79.87 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble) |
| 形态 | Crystalline |
| 颜色 | 暗红色至紫色 |
| 水溶解性 | Insoluble in water. Soluble in ethanol, and DMSO, pyridine, or dimethyl formamide. |
| ε(消光系数) | ≥10000 at 585-591nm in pyridine ≥12000 at 548-554nm in pyridine ≥135000 at 423-429nm in pyridine |
| 最大波长(λmax) | 426 nm |
| 稳定性 | Hygroscopic |
| InChIKey | FUTVBRXUIKZACV-RGGAHWMASA-K |
| SMILES | C(C1C(=C2C=C3C(C=C)=C(C)C4C=C5C(C=C)=C(C)C6=CC7C(C)=C(CCC(=O)[O-])C8N=7[Zn+2]([N-]56)(N3=4)[N-]2C=1C=8)C)CC(=O)[O-].[H+] |
| EPA化学物质信息 | Zincate(2-), [7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-.kappa.N21,.kappa.N22,.kappa.N23,.kappa.N24]-, dihydrogen, (SP-4-2)- (15442-64-5) |
安全数据
| 危险性符号(GHS) | ![]() GHS07 |
| 警示词 | 警告 |
| 危险性描述 | H302-H315-H319-H335 |
| 防范说明 | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
| WGK Germany | 3 |
| TSCA | Yes |
| 存储类别 | 11 - Combustible Solids |
锌原卟啉价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2026/09/15 | HY-101193R | 锌原卟啉 Zinc Protoporphyrin (Standard) | 15442-64-5 | 1 mg | 1600元 |
| 2026/09/15 | HY-101193 | 锌原卟啉 Zinc Protoporphyrin | 15442-64-5 | 1 mg | 650元 |
| 2026/09/15 | HY-101193R | 锌原卟啉 Zinc Protoporphyrin (Standard) | 15442-64-5 | 5 mg | 4100元 |
常见问题列表
|
Human Endogenous Metabolite
|
Zinc Protoporphyrin (Zn(II)-protoporphyrin IX; 5 μM; 72 hours) causes the fraction of late apoptotic and necrotic cells increasing from 10.9% in controls to 30.4% after 72 h.
Zinc Protoporphyrin (1.25-40 μM; 48 or 72 hours) exerts cystostatic/cytotoxic effects against tumor cells.
Zinc Protoporphyrin (2.5, 5 μM; 48 or 72 hours) results in dose- and time-dependent reduction of cells in G1 phase of the cell cycle.
Zinc Protoporphyrin (1.25-40 μM; 48 hours) leads to accumulation of cleaved (active) caspase-3.
Apoptosis Analysis
| Cell Line: | C-26 cells |
| Concentration: | 5 μM |
| Incubation Time: | 72 hours |
| Result: | The fraction of late apoptotic and necrotic cells increased from 10.9% in controls to 30.4% after 72 h. |
Cell Cytotoxicity Assay
| Cell Line: | C-26 and MDA-MB231 cells |
| Concentration: | 1.25, 2.5, 5, 10, 20, 40 μM |
| Incubation Time: | 48 or 72 hours |
| Result: | Exerted cystostatic/cytotoxic effects against tumor cells. |
Cell Cycle Analysis
| Cell Line: | C-26 cells |
| Concentration: | 2.5, 5 μM |
| Incubation Time: | 48 or 72 hours |
| Result: | Resulted in dose- and time-dependent reduction of cells in G1 phase of the cell cycle. |
Western Blot Analysis
| Cell Line: | C-26 cells |
| Concentration: | 1.25, 2.5, 5, 10, 20, 40 μM |
| Incubation Time: | 48 hours |
| Result: | Leaded to accumulation of cleaved (active) caspase-3. |
Zinc Protoporphyrin (12.5, 25, 50 mg/kg for i.p.; 12.5, 50 mg/kg for p.o.; from day 7 to 19) exerts dose-dependent antitumor effects manifested by the retardation of tumor growth.
| Animal Model: | BALB/c mice inoculated with C-26 cells |
| Dosage: | 12.5, 25, 50 mg/kg for i.p.; 12.5, 50 mg/kg for p.o. |
| Administration: | IP or PO; from day 7 to 19 |
| Result: | Exerted dose-dependent antitumor effects manifested by the retardation of tumor growth. |
